Search Results - "Rawlings-Rhea S"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL.

    Authors: Annesley C Seidel K Wu Q et al.

    Source: Blood [Blood] 2025 Aug 14; Vol. 146 (7), pp. 789-801.

    Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

    Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

    Save to List
  2. 2

    Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing.

    Authors: Appelbaum J Price AE Oda K et al.

    Source: The Journal of clinical investigation [J Clin Invest] 2024 Mar 19; Vol. 134 (9). Date of Electronic Publication: 2024 Mar 19.

    Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

    Save to List
  3. 3

    CD19 CAR T cell product and disease attributes predict leukemia remission durability.

    Authors: Finney OC Brakke HM Rawlings-Rhea S et al.

    Source: The Journal of clinical investigation [J Clin Invest] 2019 Mar 12; Vol. 129 (5), pp. 2123-2132. Date of Electronic Publication: 2019 Mar 12 (Print Publication: 2019).

    Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

    PDF Full Text
    Save to List
  4. 4

    Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

    Authors: Abdel-Azim H Dave H Jordan K et al.

    Source: Cytotherapy [Cytotherapy] 2022 Feb; Vol. 24 (2), pp. 193-204. Date of Electronic Publication: 2021 Oct 26.

    Publication Type: Journal Article; Research Support, N.I.H., Extramural

    Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

    Save to List
  5. 5

    Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.

    Authors: Vitanza NA Johnson AJ Wilson AL et al.

    Source: Nature medicine [Nat Med] 2021 Sep; Vol. 27 (9), pp. 1544-1552. Date of Electronic Publication: 2021 Jul 12.

    Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

    Save to List

Search Tools: